세계의 임상 주산기 소프트웨어 시장 규모, 점유율, 동향 분석 : 제품별, 도입 방식별, 용도별, 최종 용도별, 지역별, 부문별(2025-2030년)

Clinical Perinatal Software Market Growth & Trends:

The global clinical perinatal software market size is expected to reach USD 303.9 million in 2030 and is expected to witness a CAGR of 10.3% from 2025 to 2030. The increasing number of stillbirth cases globally is boosting the market growth.

Integrated software product segment held the largest market share in terms of revenue in 2024. Increasing demand for the workflow integration of medical professionals is anticipated to drive the growth of this segment in the forthcoming years. Moreover, technological advancements and growing adoption are the factors projected to continue fueling the segment growth over the forecast period.

In terms of application, fetal monitoring data services held the largest revenue share in 2024. These services provide accurate and adequate monitoring of fetal heartbeat and uterine contraction. Mobile fetal monitoring allows patients to remotely access the data to track the fetal development. This factor is projected to positively influence the segment growth during the forecast period.

Supportive government initiatives for maintaining maternal health are increasing the adoption of clinical perinatal software. Moreover, adoption and implementation of healthcare IT solutions such as monitoring systems in clinics, hospitals and surgical centers have increased the efficiency of work and reduced healthcare expenditure, thereby propelling the market growth.

The industry players are taking initiatives to develop new software with added data security, thus propelling further growth. For instance, in May 2018 Myriad Genetics acquired Counsyl in order to improve its portfolio in noninvasive prenatal screening.

Clinical Perinatal Software Market Report Highlights:

• On basis of product, integrated segment held the largest revenue share of 80.0% in 2024 owing to the increased adoption of this software among healthcare and clinics
• On basis of deployment model, on-premise segment held the largest revenue share, over 70.8%, in 2024 owing to its data security and ease of access
• On basis of application, workflow management software is expected to exhibit the fastest CAGR over the forecast period owing to its increased productivity and increasing adoption
• On basis of end use, hospitals and clinics dominated the market for clinical perinatal software in terms of revenue share in 2019 owing to the presence of advanced technology and increased footfall
• Asia Pacific is expected to exhibit the fastest CAGR over the forecast period. The growth can be attributed to an increase in disposable income and supportive government initiatives

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Clinical Perinatal Software Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Clinical Perinatal Software Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape.
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Clinical Perinatal Software Market: Product Estimates & Trend Analysis

• 4.1. Product Market Share, 2024 & 2030
• 4.2. Product Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Integrated
  • 4.4.1. Integrated Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Standalone
  • 4.5.1. Standalone Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Clinical Perinatal Software Market: Deployment Model Type Estimates & Trend Analysis

• 5.1. Deployment Model Market Share, 2024 & 2030
• 5.2. Deployment Model Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Deployment Model, 2018 to 2030 (USD Million)
• 5.4. On-premise
  • 5.4.1. On-premise Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Cloud-based
  • 5.5.1. Cloud-based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Clinical Perinatal Software Market: Application Estimates & Trend Analysis

• 6.1. Application Market Share, 2024 & 2030
• 6.2. Application Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Fetal Monitor Data Services
  • 6.4.1. Fetal Monitor Data Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Workflow Management
  • 6.5.1. Workflow Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Patient Documentation
  • 6.6.1. Patient Documentation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Clinical Perinatal Software Market: End Use Estimates & Trend Analysis

• 7.1. End Use Market Share, 2024 & 2030
• 7.2. End Use Segment Dashboard
• 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospital/Clinics
  • 7.4.1. Hospital/Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Maternity Clinics
  • 7.5.1. Maternity Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Clinical Perinatal Software Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 8.4. North America
  • 8.4.1. North America Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Regulatory Framework
    • 8.4.2.3. Competitive Insights
    • 8.4.2.4. U.S. Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Regulatory Framework
    • 8.4.3.3. Competitive Insights
    • 8.4.3.4. Canada Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Regulatory Framework
    • 8.4.4.3. Competitive Insights
    • 8.4.4.4. Mexico Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Regulatory Framework
    • 8.5.2.3. Competitive Insights
    • 8.5.2.4. UK Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Regulatory Framework
    • 8.5.3.3. Competitive Insights
    • 8.5.3.4. Germany Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Regulatory Framework
    • 8.5.4.3. Competitive Insights
    • 8.5.4.4. France Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Regulatory Framework
    • 8.5.5.3. Competitive Insights
    • 8.5.5.4. Italy Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Regulatory Framework
    • 8.5.6.3. Competitive Insights
    • 8.5.6.4. Spain Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Regulatory Framework
    • 8.5.7.3. Competitive Insights
    • 8.5.7.4. Denmark Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Regulatory Framework
    • 8.5.8.3. Competitive Insights
    • 8.5.8.4. Sweden Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Regulatory Framework
    • 8.5.9.3. Competitive Insights
    • 8.5.9.4. Norway Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Regulatory Framework
    • 8.6.2.3. Competitive Insights
    • 8.6.2.4. Japan Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Regulatory Framework
    • 8.6.3.3. Competitive Insights
    • 8.6.3.4. China Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Regulatory Framework
    • 8.6.4.3. Competitive Insights
    • 8.6.4.4. India Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Thailand
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Regulatory Framework
    • 8.6.5.3. Competitive Insights
    • 8.6.5.4. Thailand Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Regulatory Framework
    • 8.6.6.3. Competitive Insights
    • 8.6.6.4. South Korea Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Australia
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Regulatory Framework
    • 8.6.7.3. Competitive Insights
    • 8.6.7.4. Australia Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Regulatory Framework
    • 8.7.2.3. Competitive Insights
    • 8.7.2.4. Brazil Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Regulatory Framework
    • 8.7.3.3. Competitive Insights
    • 8.7.3.4. Argentina Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.8. Middle East and Africa
  • 8.8.1. Middle East and Africa Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Regulatory Framework
    • 8.8.2.3. Competitive Insights
    • 8.8.2.4. South Africa Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Regulatory Framework
    • 8.8.3.3. Competitive Insights
    • 8.8.3.4. Saudi Arabia Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Regulatory Framework
    • 8.8.4.3. Competitive Insights
    • 8.8.4.4. UAE Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Regulatory Framework
    • 8.8.5.3. Competitive Insights
    • 8.8.5.4. Kuwait Clinical Perinatal Software Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Participant Overview
• 9.2. Company Market Position Analysis
• 9.3. Company Categorization
• 9.4. Strategy Mapping
• 9.5. Company Profiles/Listing
  • 9.5.1. PeriGen, Inc.
    • 9.5.1.1. Participant's Overview
    • 9.5.1.2. Financial Performance
    • 9.5.1.3. Product Benchmarking
    • 9.5.1.4. Recent Developments/ Strategic Initiatives
  • 9.5.2. Koninklijke Philips N.V.
    • 9.5.2.1. Participant's Overview
    • 9.5.2.2. Financial Performance
    • 9.5.2.3. Product Benchmarking
    • 9.5.2.4. Recent Developments/ Strategic Initiatives
  • 9.5.3. Trium Analysis Online GmbH
    • 9.5.3.1. Participant's Overview
    • 9.5.3.2. Financial Performance
    • 9.5.3.3. Product Benchmarking
    • 9.5.3.4. Recent Developments/ Strategic Initiatives
  • 9.5.4. EDAN Instruments, Inc.
    • 9.5.4.1. Participant's Overview
    • 9.5.4.2. Financial Performance
    • 9.5.4.3. Product Benchmarking
    • 9.5.4.4. Recent Developments/ Strategic Initiatives
  • 9.5.5. K2 Medical Systems Ltd.
    • 9.5.5.1. Participant's Overview
    • 9.5.5.2. Financial Performance
    • 9.5.5.3. Product Benchmarking
    • 9.5.5.4. Recent Developments/ Strategic Initiatives
  • 9.5.6. Huntleigh Healthcare Limited.
    • 9.5.6.1. Participant's Overview
    • 9.5.6.2. Financial Performance
    • 9.5.6.3. Product Benchmarking
    • 9.5.6.4. Recent Developments/ Strategic Initiatives
  • 9.5.7. Clinical Computer Systems, Inc.
    • 9.5.7.1. Participant's Overview
    • 9.5.7.2. Financial Performance
    • 9.5.7.3. Product Benchmarking
    • 9.5.7.4. Recent Developments/ Strategic Initiatives
  • 9.5.8. General Electric Company
    • 9.5.8.1. Participant's Overview
    • 9.5.8.2. Financial Performance
    • 9.5.8.3. Product Benchmarking
    • 9.5.8.4. Recent Developments/ Strategic Initiatives